Last reviewed · How we verify

NCT03912467: PRESSURE

Prevalence of Pressure Ulcers Among Critically Ill Patients and Factors Associated With Their Occurrence in the ICU

Completed Last updated 11 April 2019
What this trial tests

trial testing Pressure Ulcer Evaluation in Pressure Ulcer in 1,228 participants. Completed in 1 December 2017.

Timeline
1 June 2017
Primary endpoint
1 June 2017
1 December 2017

Quick facts

Lead sponsorFrench Society for Intensive Care
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,228
Start date1 June 2017
Primary completion1 June 2017
Estimated completion1 December 2017
Sites60 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

French Society for Intensive Care

Who can join

18 and older, any sex, with Pressure Ulcer or Critical Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The prevalence of and risk factors for pressure ulcers (PUs) in critically ill patients have been poorly studied. The main objective of this study was to describe the prevalence of PUs in critically ill patients. Secondary objectives were to describe PUs, means of prevention of PUs, and factors associated with occurrence of PUs in the ICU.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pressure Ulcer

Currently open trials in the same condition.

Other French Society for Intensive Care trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03912467.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing